168 related articles for article (PubMed ID: 37800692)
1. Association of Glycated Hemoglobin With a Risk of Pancreatic Cancer in High-Risk Individuals Based on Genetic and Family History.
Wu BU; Chen Q; Moon BH; Lustigova E; Nielsen EG; Alvarado M; Ahmed SA
Clin Transl Gastroenterol; 2024 Jan; 15(1):e00650. PubMed ID: 37800692
[TBL] [Abstract][Full Text] [Related]
2. Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines.
Bennett C; Suguitan M; Abad J; Chawla A
Pancreatology; 2022 Sep; 22(6):719-729. PubMed ID: 35798629
[TBL] [Abstract][Full Text] [Related]
3. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
4. Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations.
Yang XR; Rotunno M; Xiao Y; Ingvar C; Helgadottir H; Pastorino L; van Doorn R; Bennett H; Graham C; Sampson JN; Malasky M; Vogt A; Zhu B; Bianchi-Scarra G; Bruno W; Queirolo P; Fornarini G; Hansson J; Tuominen R; Burdett L; Hicks B; Hutchinson A; Jones K; Yeager M; Chanock SJ; Landi MT; Höiom V; Olsson H; Gruis N; Ghiorzo P; Tucker MA; Goldstein AM
Hum Genet; 2016 Nov; 135(11):1241-1249. PubMed ID: 27449771
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer screening in high-risk individuals with germline genetic mutations.
DaVee T; Coronel E; Papafragkakis C; Thaiudom S; Lanke G; Chakinala RC; Nogueras González GM; Bhutani MS; Ross WA; Weston BR; Lee JH
Gastrointest Endosc; 2018 Jun; 87(6):1443-1450. PubMed ID: 29309780
[TBL] [Abstract][Full Text] [Related]
6. Hereditary pancreatic cancer.
Abe K; Kitago M; Kitagawa Y; Hirasawa A
Int J Clin Oncol; 2021 Oct; 26(10):1784-1792. PubMed ID: 34476650
[TBL] [Abstract][Full Text] [Related]
7. Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants.
Murali K; Dwarte TM; Nikfarjam M; Tucker KM; Vaughan RB; Efthymiou M; Collins A; Spigelman AD; Salmon L; Johns AL; Williams DB; Delatycki MB; John T; Stoita A
Hered Cancer Clin Pract; 2021 Aug; 19(1):33. PubMed ID: 34399810
[TBL] [Abstract][Full Text] [Related]
8. Inherited pancreatic cancer syndromes.
Solomon S; Das S; Brand R; Whitcomb DC
Cancer J; 2012; 18(6):485-91. PubMed ID: 23187834
[TBL] [Abstract][Full Text] [Related]
9. Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening?
Roch AM; Kim RC; Nguyen TK; House MG; Zyromski NJ; Nakeeb A; Schmidt CM; Ceppa EP
J Surg Oncol; 2023 Aug; 128(2):289-294. PubMed ID: 37083062
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.
Grant RC; Selander I; Connor AA; Selvarajah S; Borgida A; Briollais L; Petersen GM; Lerner-Ellis J; Holter S; Gallinger S
Gastroenterology; 2015 Mar; 148(3):556-64. PubMed ID: 25479140
[TBL] [Abstract][Full Text] [Related]
11. Familial pancreatic carcinoma in Jews.
Lynch HT; Deters CA; Lynch JF; Brand RE
Fam Cancer; 2004; 3(3-4):233-40. PubMed ID: 15516847
[TBL] [Abstract][Full Text] [Related]
12. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
Aslanian HR; Lee JH; Canto MI
Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
[TBL] [Abstract][Full Text] [Related]
13. Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
Chen X; Meyer MA; Kemppainen JL; Horibe M; Chandra S; Majumder S; Petersen GM; Rabe KG
JAMA Oncol; 2023 Jul; 9(7):955-961. PubMed ID: 37200008
[TBL] [Abstract][Full Text] [Related]
14. CFTR, SPINK1, PRSS1, and CTRC mutations are not associated with pancreatic cancer in German patients.
Schubert S; Traub F; Brakensiek K; von Kopylow K; Marohn B; Maelzer M; Gaedcke J; Kreipe H; Stuhrmann M
Pancreas; 2014 Oct; 43(7):1078-82. PubMed ID: 25003218
[TBL] [Abstract][Full Text] [Related]
15. The Frequency of Germline BRCA and Non-BRCA HR-Gene-Variants in a Cohort of Pancreatic Cancer Patients.
Baz M; Gondran-Teiller V; Bressac B; Cabaret O; Fievet A; Dimaria M; Goldbarg V; Colas C; Bonnet-Dupeyron MN; Tinat J; Lebrun M; Mari V; Limacher JM; Corsini C; Ginglinger E; Saurin JC; Brahimi A; Rouzier C; Giraud S; Schuster H; Hollebecque A; Boige V; Cauchin E; Malka D; Caron O; Rouleau E
Dig Dis Sci; 2023 Apr; 68(4):1525-1528. PubMed ID: 36315333
[TBL] [Abstract][Full Text] [Related]
16. Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer.
Krepline AN; Geurts JL; Akinola I; Christians KK; Clarke CN; George B; Ritch PS; Khan AH; Hall WA; Erickson BA; Griffin MO; Evans DB; Tsai S
HPB (Oxford); 2020 Dec; 22(12):1745-1752. PubMed ID: 32354656
[TBL] [Abstract][Full Text] [Related]
17. Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?
Wang Y; Cuggia A; Chen YI; Parent J; Stanek A; Denroche RE; Zhang A; Grant RC; Domecq C; Golesworthy B; Shwaartz C; Borgida A; Holter S; Wilson JM; Chong G; O'Kane GM; Knox JJ; Fischer SE; Gallinger S; Gao ZH; Foulkes WD; Waschke KA; Zogopoulos G
J Natl Compr Canc Netw; 2022 Jun; 20(6):663-673.e12. PubMed ID: 35714671
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer risk to siblings of probands in bilineal cancer settings.
Rabe KG; Stevens MA; Hernández AT; Chandra S; Hubbard JM; Kemppainen JL; Majumder S; Petersen GM
Genet Med; 2022 May; 24(5):1008-1016. PubMed ID: 35227607
[TBL] [Abstract][Full Text] [Related]
19. Association of Glycated Hemoglobin Levels With Risk of Pancreatic Cancer.
Wu BU; Butler RK; Lustigova E; Lawrence JM; Chen W
JAMA Netw Open; 2020 Jun; 3(6):e204945. PubMed ID: 32530471
[TBL] [Abstract][Full Text] [Related]
20. Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge.
Bono M; Fanale D; Incorvaia L; Cancelliere D; Fiorino A; Calò V; Dimino A; Filorizzo C; Corsini LR; Brando C; Madonia G; Cucinella A; Scalia R; Barraco N; Guadagni F; Pedone E; Badalamenti G; Russo A; Bazan V
ESMO Open; 2021 Aug; 6(4):100235. PubMed ID: 34371384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]